- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07465055
Operating Room Extubation and Postoperative Outcomes in Neonates With Meningomyelocele (MEROX)
March 7, 2026 updated by: Recep Karakaşoğlu, Gaziantep City Hospital
Impact of Operating Room Extubation on Postoperative Outcomes in Neonates Undergoing Meningomyelocele Repair: A Retrospective Cohort Study
Meningomyelocele is one of the most common neural tube defects requiring surgical repair in the neonatal period.
Postoperative respiratory complications and the need for prolonged mechanical ventilation are important causes of morbidity in these patients.
The timing of extubation may influence postoperative respiratory outcomes and the duration of neonatal intensive care unit (NICU) stay.
This retrospective cohort study aims to evaluate the impact of operating room extubation on postoperative outcomes in neonates undergoing meningomyelocele repair at Gaziantep City Hospital.
Clinical, laboratory, and perioperative data will be obtained from hospital records.
Postoperative mechanical ventilation requirement, duration of ventilation, NICU length of stay, and perioperative laboratory changes will be compared between neonates extubated in the operating room and those extubated in the intensive care unit.
Study Overview
Status
Active, not recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gaziantep
-
Gaziantep, Gaziantep, Turkey (Türkiye), 27000
- Gaziantep City Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Neonates who underwent meningomyelocele repair under general anesthesia at Gaziantep City Hospital between November 2023 and March 2026.
All patients were followed postoperatively in the neonatal intensive care unit, and perioperative clinical and laboratory data were obtained from hospital medical records.
Description
Inclusion Criteria:
- Neonates undergoing surgical repair of meningomyelocele
- Surgery performed under general anesthesia
- Age ≤ 28 days at the time of surgery
- Postoperative follow-up in the neonatal intensive care unit (NICU)
- Availability of complete perioperative clinical and laboratory data
Exclusion Criteria:
- Preoperative respiratory distress requiring invasive or non-invasive ventilatory support
- Major congenital anomalies or severe comorbidities (e.g., complex congenital heart disease, severe pulmonary disease, chromosomal abnormalities)
- Neonates with poor postnatal adaptation (5-minute Apgar score < 7)
- Preoperative hemodynamic instability
- Severe prematurity-related respiratory morbidity
- Prolonged mechanical ventilation due to causes unrelated to meningomyelocele surgery
- Incomplete or missing perioperative medical records
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Operating Room Extubation
Neonates who were extubated in the operating room immediately after meningomyelocele repair.
|
|
ICU Extubation
Neonates who were transferred intubated to the NICU and extubated in the intensive care unit after meningomyelocele repair.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative Mechanical Ventilation Requirement
Time Frame: Within the first 48 hours after surgery
|
Requirement for invasive mechanical ventilation after meningomyelocele repair in neonates.
|
Within the first 48 hours after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of NICU Stay
Time Frame: From surgery until discharge from the neonatal intensive care unit, up to 30 days
|
Duration of stay in the neonatal intensive care unit following meningomyelocele repair.
|
From surgery until discharge from the neonatal intensive care unit, up to 30 days
|
|
Change in Blood pH
Time Frame: Preoperative vs postoperative 24 hours
|
Difference between preoperative and postoperative blood pH values.
|
Preoperative vs postoperative 24 hours
|
|
Change in Lactate Level
Time Frame: Baseline (preoperative) and 24 hours after surgery
|
Difference between preoperative and postoperative blood lactate levels.
|
Baseline (preoperative) and 24 hours after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Recep Karakaşoğlu, MD, Gaziantep City Hospital
- Study Chair: Sinan Ünsal, MD, Gaziantep City Hospital
- Study Director: Burak C. Balık, MD, Gaziantep City Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2023
Primary Completion (Actual)
March 1, 2026
Study Completion (Estimated)
May 20, 2026
Study Registration Dates
First Submitted
March 4, 2026
First Submitted That Met QC Criteria
March 7, 2026
First Posted (Actual)
March 11, 2026
Study Record Updates
Last Update Posted (Actual)
March 11, 2026
Last Update Submitted That Met QC Criteria
March 7, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Gazianestreamenex
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myelomeningocele
-
Assistance Publique - Hôpitaux de ParisActive, not recruitingNeural Tube Defects | Spina Bifida | Sacral MyelomeningoceleFrance
-
Assistance Publique - Hôpitaux de ParisUnité de Recherche Clinique Necker Cochin, FranceCompleted
-
University of Nove de JulhoUnknownMotor Activity | Myelomeningocele Without Hydrocephalus | Sensory Defect
-
Bailey PetersenRecruiting
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Assiut UniversityNot yet recruitingMyelomeningocele
-
St. Louis UniversitySSM HealthTerminatedPregnancy | MyelomeningoceleUnited States
-
St. Louis UniversityTerminatedPregnancy | MyelomeningoceleUnited States
-
Superior UniversityActive, not recruitingMyelomeningocelePakistan
-
The George Washington University Biostatistics...Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedSpinal Dysraphism | MeningomyeloceleUnited States